Literature DB >> 12890817

The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.

M Vainzof1, F de Paula, A M Tsanaclis, M Zatz.   

Abstract

Limb girdle muscular dystrophy type 2A (LGMD2A) is caused by mutations in the calpain 3 gene. In a large family affected by LGMD2A with four severely affected members, three additional asymptomatic relatives had very high serum creatine kinase concentrations. All were homozygous for the R110X mutation and showed a total absence of calpain 3 in the muscle. Histological analysis of muscle in these three rare preclinical cases showed a consistent but unusual pattern, with isolated fascicles of degenerating fibres in an almost normal muscle. This pattern was also seen in one patient with early stage LGMD2A who had a P82L missense mutation and a partial deficiency of calpain 3 in the muscle, but was not seen in early stage patients affected by other forms of LGMD. These findings suggest that a peculiar pattern of focal degeneration occurs in calpainopathy, independently of the type of mutation or the amount of calpain 3 in the muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890817      PMCID: PMC1770017          DOI: 10.1136/jcp.56.8.624

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.

Authors:  S Baghdiguian; M Martin; I Richard; F Pons; C Astier; N Bourg; R T Hay; R Chemaly; G Halaby; J Loiselet; L V Anderson; A Lopez de Munain; M Fardeau; P Mangeat; J S Beckmann; G Lefranc
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002.

Authors:  K M D Bushby; J S Beckmann
Journal:  Neuromuscul Disord       Date:  2003-01       Impact factor: 4.296

3.  Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families.

Authors:  M R Passos-Bueno; E S Moreira; S K Marie; R Bashir; L Vasquez; D R Love; M Vainzof; P Iughetti; J R Oliveira; E Bakker; T Strachan; K Bushby; M Zatz
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

4.  Calpainopathy-a survey of mutations and polymorphisms.

Authors:  I Richard; C Roudaut; A Saenz; R Pogue; J E Grimbergen; L V Anderson; C Beley; A M Cobo; C de Diego; B Eymard; P Gallano; H B Ginjaar; A Lasa; C Pollitt; H Topaloglu; J A Urtizberea; M de Visser; A van der Kooi; K Bushby; E Bakker; A Lopez de Munain; M Fardeau; J S Beckmann
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 5.  Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes.

Authors:  M Zatz; M Vainzof; M R Passos-Bueno
Journal:  Curr Opin Neurol       Date:  2000-10       Impact factor: 5.710

6.  Evidence of genetic heterogeneity in the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families.

Authors:  M R Passos-Bueno; I Richard; M Vainzof; F Fougerousse; J Weissenbach; O Broux; D Cohen; J Akiyama; S K Marie; A A Carvalho
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

7.  A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage.

Authors:  J S Beckmann; I Richard; D Hillaire; O Broux; C Antignac; E Bois; H Cann; R W Cottingham; N Feingold; J Feingold
Journal:  C R Acad Sci III       Date:  1991

8.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

Authors:  I Richard; O Broux; V Allamand; F Fougerousse; N Chiannilkulchai; N Bourg; L Brenguier; C Devaud; P Pasturaud; C Roudaut
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

9.  Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A.

Authors:  L V Anderson; K Davison; J A Moss; I Richard; M Fardeau; F M Tomé; C Hübner; A Lasa; J Colomer; J S Beckmann
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  Clinical variability in calpainopathy: what makes the difference?

Authors:  Flávia de Paula; Mariz Vainzof; Maria Rita Passos-Bueno; Rita de Cássia M Pavanello; Sergio Russo Matioli; Louise V B Anderson; Vincenzo Nigro; Mayana Zatz
Journal:  Eur J Hum Genet       Date:  2002-12       Impact factor: 4.246

  10 in total
  5 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  C3KO mouse expression analysis: downregulation of the muscular dystrophy Ky protein and alterations in muscle aging.

Authors:  Oihane Jaka; Irina Kramerova; Margarita Azpitarte; Adolfo López de Munain; Melissa Spencer; Amets Sáenz
Journal:  Neurogenetics       Date:  2012-07-22       Impact factor: 2.660

3.  Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Melissa J Spencer
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

4.  Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem Cells.

Authors:  Kilian Mazaleyrat; Cherif Badja; Natacha Broucqsault; Raphaël Chevalier; Camille Laberthonnière; Camille Dion; Lyla Baldasseroni; Claire El-Yazidi; Morgane Thomas; Richard Bachelier; Alexandre Altié; Karine Nguyen; Nicolas Lévy; Jérôme D Robin; Frédérique Magdinier
Journal:  Cells       Date:  2020-06-23       Impact factor: 6.600

5.  Creating a 'Molecular Band-Aid'; Blocking an Exposed Protease Target Site in Desmoplakin.

Authors:  Catherine A Hoover; Kendahl L Ott; Heather R Manring; Trevor Dew; Maegen A Borzok; Nathan T Wright
Journal:  J Pers Med       Date:  2021-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.